Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Platinum-resistant Fallopian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06828354
What this trial is testing

SHR-A1811 in Subjects With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd. 300
Testing effectiveness (Phase 2)WithdrawnNCT01766622
What this trial is testing

18F-CP18 Imaging Studies for Cancer Treatment With Birinapant

Who this might be right for
Ovarian NeoplasmsOvarian CancerFallopian Tube Neoplasms+1 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07265739
What this trial is testing

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Who this might be right for
Platinum Resistant Ovarian Cancer
Massachusetts General Hospital 27
Large-scale testing (Phase 3)Not Yet RecruitingNCT06990503
What this trial is testing

SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Tongji Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT06787612
What this trial is testing

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Regeneron Pharmaceuticals 297
Testing effectiveness (Phase 2)Study completedNCT03776812
What this trial is testing

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Ovarian CancerRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal Carcinoma
Corcept Therapeutics 178
Testing effectiveness (Phase 2)Study completedNCT00993616
What this trial is testing

Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+7 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT00853307
What this trial is testing

MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma

Who this might be right for
Ovarian Carcinoma
Millennium Pharmaceuticals, Inc. 31
Early research (Phase 1)Active Not RecruitingNCT01883297
What this trial is testing

"Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
RecurrentPlatinum-resistantHigh Grade Serous Ovarian Cancer+2 more
University Health Network, Toronto 3
Testing effectiveness (Phase 2)Study completedNCT01853644
What this trial is testing

Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Recurrent Epithelial Ovarian CancerRecurrent Fallopian Tube CancerRecurrent Primary Peritoneal Cancer
Northwestern University 31
Large-scale testing (Phase 3)Study completedNCT02855944
What this trial is testing

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 349
Testing effectiveness (Phase 2)Active Not RecruitingNCT03113487
What this trial is testing

P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Platinum-Resistant Fallopian Tube CarcinomaRecurrent Platinum-Resistant Ovarian CarcinomaRecurrent Platinum-Resistant Primary Peritoneal Carcinoma
City of Hope Medical Center 29
Testing effectiveness (Phase 2)Study completedNCT02901899
What this trial is testing

Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Northwestern University 45
Large-scale testing (Phase 3)Looking for participantsNCT07604766
What this trial is testing

An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China

Who this might be right for
Platinum-resistant Ovarian Cancer
Genmab 82
Large-scale testing (Phase 3)Active Not RecruitingNCT06834672
What this trial is testing

Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
OvarianPrimary PeritonealFallopian Tube Cancer
Innovent Biologics (Suzhou) Co. Ltd. 450
Testing effectiveness (Phase 2)Study completedNCT02865811
What this trial is testing

Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Dana-Farber Cancer Institute 26
Testing effectiveness (Phase 2)Ended earlyNCT02575807
What this trial is testing

Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer

Who this might be right for
Platinum-resistant Ovarian CancerPlatinum-resistant Fallopian CancerPlatinum-resistant Peritoneal Cancer
Aduro Biotech, Inc. 35
Testing effectiveness (Phase 2)Ended earlyNCT00354601
What this trial is testing

Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Wake Forest University Health Sciences 2
Testing effectiveness (Phase 2)Study completedNCT03480750
What this trial is testing

Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasms Malignant (Excl Germ Cell)Peritoneal CarcinomaFallopian Tube Cancer
National Cheng-Kung University Hospital 18
Large-scale testing (Phase 3)Ended earlyNCT02641639
What this trial is testing

FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer

Who this might be right for
Platinum Resistant Ovarian Cancer
Mateon Therapeutics 70
Next Page